{"organizations": [], "uuid": "55a11a813724e0fd553ec6ff6df2e92bd92d6e08", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/funds", "section_title": "Best Mutual Funds and ETFs | Reuters.com", "url": "https://www.reuters.com/article/brief-pear-therapeutics-completes-50-mil/brief-pear-therapeutics-completes-50-million-series-b-financing-idUSASB0BZES", "country": "US", "domain_rank": 408, "title": "BRIEF-Pear Therapeutics Completes $50 Million Series B Financing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.054, "site_type": "news", "published": "2018-01-02T21:09:00.000+02:00", "replies_count": 0, "uuid": "55a11a813724e0fd553ec6ff6df2e92bd92d6e08"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-pear-therapeutics-completes-50-mil/brief-pear-therapeutics-completes-50-million-series-b-financing-idUSASB0BZES", "ord_in_thread": 0, "title": "BRIEF-Pear Therapeutics Completes $50 Million Series B Financing", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 2 (Reuters) - Pear Therapeutics:\n* PEAR THERAPEUTICS COMPLETES $50 MILLION SERIES B FINANCING\n* PEAR THERAPEUTICS - SUCCESSFULLY CLOSED ‚Äç$50 MILLION SERIES B FINANCING LED BY TEMASEK Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-02T21:09:00.000+02:00", "crawled": "2018-01-02T18:17:35.010+02:00", "highlightTitle": ""}